Annis Gardner Whiting Capital Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $352 Billion
- Q2 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 9,396 shares of IONS stock, worth $361,370. This represents 0.13% of its overall portfolio holdings.
Number of Shares
9,396Holding current value
$361,370% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
386Shares Held
125MCall Options Held
2.19MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$533 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$486 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$397 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$318 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$253 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.46B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...